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time of infection, naloxone or naltrexone were added 
in the absence or presence of zidovudine (AZT) or 
indinavir, at concentrations selected to give suboptimal 
(about 25%) viral suppression (measured by quantifying 
p24 antigen in culture supernatants) 
Results: While neither naloxone nor naltrexone alone 
displayed any anti-HIV-l activity, at concentrations bet- 
ween 1O-‘4-1O-s M, these opiate antagonists potentiated 
by 2-3 fold the antiviral activity of AZT and indinavir 
against both HIV-l AT and HIV-1~~162. The synergistic 
effect of naloxone/ naltrexone was dose-dependent with 
maximal stimulation in the picomolar to nanomolar 
range. Similar results with a K-OpiOid receptor (KOR) 
selective antagonist supported involvement of KOR in 
naloxone’s potentiation of antiretroviral drugs. 
Conclusions: Naloxone potently enhances the anti-HIV- 
1 activity of AZT and indinavir in CD4’ lymphocytes 
in vitro. Since naltrexone is a safe and relatively in- 
expensive drug that can be administered orally, clinical 
trials should be considered to see if this opiate antagonist 
also potentiates the activity of antiretrovirals in vivo. 
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Objective: Toxoplasmic encephalitis (TE), the leading 
cause of focal cerebral lesions in patients with AIDS, is 
presumed to result from recrudescence of latent 
Toxoplasma gondii infection. Since treatment of a TE 
episode requires life-long maintenance therapy, which 
may cause considerable toxicity, this remains a major 
therapeutic problem. Following up on our observations 
of a synergistic effect of atovaquone (ATO) and 
clindamycin (CLI) in acute murine toxoplasmosis, the 
effect of this drug combination was evaluated in a 
murine model of corticoid-drug induced recrudescence 
of chronic infection. 
Experimental design: Swiss-Webster mice with chronic 
toxoplasmosis established by intraoesophageal inocu- 
lation of 10 cysts of the Me49 strain of T gondii 3 months 
previously, were immunosuppressed with: a) dexa- 
methasone (DXM) at 2.5 mg/kg/day in drinking water 
(5 mg/L) alone or combined with cortisone-acetate (CA) 
at 50 mglkg by SC injection 3 times/ week during 3 weeks, 
and then treated with ATO+CLI at 5+25 and 50+50 
mg/kg/day for 4 weeks, and b) DXM alone during 2 
weeks, and treated with ATO+CLI at 25+50, 50+50, 
and 100+400 mg/kg/day for 3 weeks. Treatment effects 
were monitored by survival and brain cyst counts 
immediately after treatment (a), and both after treat- 
ment and 12 weeks later (b). 
Results: In chronically infected mice, corticoid admini- 
stration induced recrudescence of T gondii within 
weeks. The dramatically decreased survival rates and 
significantly increased brain cyst burdens compared 
to untreated mice, were both more expressed in mice 
suppressed with DXM+CA than with DXM alone. 
Treatment of immunosuppressed mice with AT0 and 
CL1 had a beneficial effect which was directly dependent 
on the drug dose, and indirectly on the level of immuno- 
suppression. Compared to 0% survival in untreated 
immunosuppressed controls, treatment with ATO+CLI 
at 50+50 mg/kg/day protected 30% DXM+CA pre- 
treated mice, while reducing the mean cyst burdens by 
4-fold. In mice pre-treated with DXM alone, the survival 
rate of 9% in untreated mice was elevated to 55-67% 
(PcO.05) in those treated depending on the dose 
regimen, and associated with markedly decreased cyst 
burdens (PcO.01). The latter effect was long-term since 
the cyst burdens in treated animals continued to 
decrease over the next 3 months, while significantly 
(PcO.01) rising in the control ones. 
Conclusions: The data presented suggest that the 
combination of AT0 and CL1 may be a novel option 
for the treatment of toxoplasmosis in the setting of 
immunosuppression, warranting its clinical evaluation. 
Paracoccidioidomycosis and AIDS: report of a case 
M. Sandoval, A. Marcano, X. Guerra, J. R. Cermeiio.’ 
Departamento de Medicina, Complejo Hospitalario 
Universitario “Ruiz y Paez “. t Departamento de 
Parasitologia y Microbiologia, Universidad De Oriente. 
Escuela de Medicina, Ciudad Boli’var, Edo. Bolivar. 
Venezuela 
e-mail: dramarisolsandoval@cantv,net 
Paracoccidioidomycosis is a deep-seated systemic 
infection of humans caused by the thermal dimorphic 
fungus Paracoccidiodes brasiliensis and a major problem 
in Central and South America. On the other hand, AIDS 
epidemic can influence the evolution of endemic in- 
fectious diseases. A case of paracoccidioidomycosis in 
a patient with AIDS is described, this is the first 
association of paracoccidioidomycosis with AIDS in 
Bolivar State, Venezuela, a paracoccidioidomycosis 
endemic zone. The patient was a 39 years old-man 
admitted to the hospital because of dyspnea, fever and 
wasting syndrome. The clinical presentation was an acute 
respiratory distress syndrome with severe hypoxemia 
and bilateral pulmonary infiltrates. In addition, oral 
moniliasis, low platelet, and elevated aminotransferases 
were found. Stools examination demonstrated hook- 
worm eggs and Giardia lamblia. An enzyme-linked 
immunosorbent assay and a Western blot assay for HIV- 
1 antibodies were positive, the CD4 cell count was 42 x 
mm3. The direct examination of the sputum (KOH) 
demon-strated multiple budding yeast cells: of F! 
brasiliensis; Gram stain was positive for Gram negative 
bacilli and high white cells count Gram negative bacilli; 
Ziehl-Neelsen and direct immunofluorescence for 
Pneumocystis carinii were negative. Sputum culture 
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were positive for Klebsiella pneumoniae and p 
brasiliensis. The serologic test for R brasiliensis was 
negative. Under suspect of R carinii infection therapy 
whith Trimethoprim-sulfamethoxa zole plus Prednisone 
and Fluconazole was initially and after Imipenem and 
Amphotericin B was administered. During the next 
several days the patient condition improved. It is 
suggested that the determining factor for paracoccid- 
ioidomycosis in HIV-infected patients is the immune 
imbalance caused by the infection, documented by the 
low CD4 cell count. Although this clinical presentation 
suggested an acute infection for F! carinii, it is endemic 
microorganism can also be included in the diferential 
diagnosis. Most cases of paracoccidioidomycosis in 
patients with AIDS could be expected to occur in 
endemic areas for I? brasiliensis. 
Atypical presentation of syphilis in advanced HIV 
infection: case report and review 
S. Haider, * .I. Jovanovich2 
Mcmaster University Medical Centre Hamilton Ont 
Canada*, Henry Ford Hospital Detroit MI USA2 
Background: The skin is the most common organ of in- 
volvement in human immunodeficiency virus (HIV) 
infection. As with other opportunistic infections, there 
has been a decline in cutaneous diseases in the post 
highly active antiretroviral therapy era (HAART). 
HAART therapy has not impacted on the incidence of 
syphilis. Syphilis and HIV infection often coexist as they 
are acquired from similar high risk exposures. In 
advanced HIV infection altered cell mediated immunity 
and polyclonal B-cell activation can lead to atypical 
clinical and serological presentations. 
Case: A 44 year African American homosexual male 
diagnosed 2 months ago with HIV infection presented 
with history of 10 pound weight loss, and the presence 
of hyperpigmented violaceous lesions first noted on his 
left leg and subsequently on his thigh and sacrum. These 
lesions were painless and nonpruritic. The patient 
had noted an ulceration on his penis 6 weeks prior 
to presentation. The patient admitted to unprotected 
intercourse. On examination he appeared cachectic. 
Skin was remarkable for well demarcated violaceous 
hyperpigmented plaques with some nodularity on left 
lower extremity, thigh and sacral areas. Also noted was 
a shallow painless ulcer on the glans penis with no 
raised edges. Laboratory data showed a CD4 count of 88 
cells/ mm43(6%) and HIV-l viral load of 750,000 copies/ 
ml. Serum RPR showed a titer of 1:16384 dilution, FTA- 
ABS positive, a CSF analysis showed a WBC of 16 and 
CSF VDRL positive at 1:16 dilution. A skin biopsy 
showed thinning of the epidermal layer with charac- 
teristic superficial and deep psoriasiform lichenoid 
pattern of mixed inflammation of lymphocytes, histio- 
cytes, and plasma cells. (Figure 3) Skin biopsy was 
positive by Warthin-Starry stains.The patient was treated 
for 14 days with IV penicillin with partial improvement 
in skin lesions. 
Discussion: Between 1989 to 1993,25% of all cases of 
syphilis in the United States occurred in HIV infected 
patients. In advanced HIV infection a switch from Th-1 
to Th-2 subset of T helper cells promotes an allergic 
response. This alteration in subset of T helper cells 
accounts for the varied clinical and serological presen- 
tations in HIV The spectrum of clinical presentation 
of syphilis in HIV includes nodules, papules, vesicles, 
hyperkeratotic plaques, papulosquamous, scleroderma- 
tous changes, and vasculitis. To our knowledge this is the 
first report of a violaceous hyperpigmented skin lesion 
that could easily be confused with Kaposi’s sarcoma, or 
bacillary angiomatosis. 
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Visceral leishmaniasis occurs widely in the world and 
sporadic cases are encountered among children and 
immunocompromised persons including those with 
AIDS. We describe a case of visceral leishmaniasis 
occurred as first manifestation of HIV infection. 
The case: A.M., a 51 year-old man was admitted to the 
Infectious Disease Department of Lucca because of a 
high fever of l-month durationThe physical examination 
revealed an enlarged liver and spleen, pharyngeal 
candidosis and oral hairy leukoplakya. Blood cells count 
was as follows: red cells 5.050.000/ mmc, hemoglobin 
14 g/l, leukocyte 3.490/mmc (neutrophyl cells 82,7%, 
lymphocytes 8,7%), platelets 51.000/mmc. Plasmatic 
levels of urea, creatinine, alanine aminotransferase, 
aspartate aminotransferase, amylase, total protein were 
normal. Serology for HIV was positive for the first time, 
the immunologic and virologic status revealed CD4+ 14 
cell/mcl, CD8+ 118 cell/mcl, viral load 14.000 cp/ml. 
Abdominal and cardiac ultrasonography and total body 
CT scan did not reveal pathological images; serologic 
tests for Epstein Barr virus, cytomegalovirus, herpes 
simplex virus, Leishmania sp., Criptococcus sp., and 
Treponema pallidum were negative. Microbiological 
research for M. tuberculosis and atypical micro-bacteria 
on sputum, urine and stools were negative; urine cultures 
and sputum cultures for aerobic and anaerobic bacteri 
and myceti were negative too. After four emocultures 
resulted all negative, the patient was treated with empiric 
antibiotic therapy (cefotaxime) without resolution of 
fever. After 5 days from admission a cranial MRI 
was performed and a little solitary hypodence contrast- 
enhanced cerebral lesion was detectable. In the suspect 
of neurotoxoplasmosis a treatment with pyrimethamine 
